Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • ResultsCX Wins Two 2024 Fortress Cybersecurity Awards

    Jun 21, 2024, 09:31 AM by
    Full story
  • Aranscia and Signature RX Announce Personalized Medication Management Program for GLP-1s

    Jun 21, 2024, 09:31 AM by
    Full story
  • Bora Pharmaceuticals Expands North American Footprint with Agreement to Acquire First Sterile Manufacturing Facility

    Jun 21, 2024, 09:31 AM by
    Full story
  • When Banks Say ‘No’ to Equipment Financing, It’s Not the End of the Story

    Jun 21, 2024, 05:00 AM by User Not Found
    Bio-IT World | Thanks to emerging technologies, from generative AI to data platforms and robotic solutions, companies in the biotech and life science sectors are achieving amazing advances. But for every headline showcasing a success, there is a reminder of the abiding industry reality: countless promising companies are still struggling to acquire the equipment and technology they need to fuel product development and platform growth.
    Full story
  • Clinion and Clinevo’s Strategic Alliance for An Integrated eClinical Experience

    Jun 20, 2024, 07:10 AM by
    AI-powered eClinical Platform, Clinion, announces strategic partnership with eClinical safety solutions provider, Clinevo.
    Full story
  • ZeOmega Launches HealthFeed SMS Texting for Enhanced Member Engagement

    Jun 20, 2024, 07:10 AM by
    Full story
  • TP-ACO Selects YouScript for Personalized Medication Management Initiative

    Jun 20, 2024, 07:10 AM by
    Full story
  • AKASA Unveils AKASA Medical CodingTM for Enhanced Revenue Cycle Management with Generative AI

    Jun 20, 2024, 07:10 AM by
    Full story
  • Cresset Successfully Achieves SOC 2 Compliance

    Jun 20, 2024, 07:10 AM by
    Full story
  • Avoiding the Traps and Pitfalls of Artificial Intelligence Development

    Jun 19, 2024, 05:00 AM by User Not Found
    Bio-IT World | Artificial intelligence (AI) was the main topic at the 2024 Bio-IT World Conference & Expo. While there was much excitement over new developments, there were also many discussions covering the obstacles that block the path to further progress—many of which have nothing to do with technology or data.
    Full story
  • Instem And Proscia Partner To Accelerate Preclinical Development With Digital Pathology

    Jun 18, 2024, 07:47 AM by
    Instem, a leading provider of IT solutions and services to the global life sciences market, has partnered with Proscia®, a global leader in AI-enhanced pathology solutions for precision medicine.
    Full story
  • CluePoints Continues ‘Turning Artificial Intelligence into Human Intelligence’ by Launching Two New Innovations

    Jun 18, 2024, 07:47 AM by
    CluePoints Continues ‘Turning Artificial Intelligence into Human Intelligence’ by Launching Two New Innovations Site Profile & Oversight Tool (SPOT) and Intelligent Medical Coding (IMC) unveiled by RBQM innovator at DIA Global Annual Meeting 2024
    Full story
  • Regeneron’s Platform Play for Protein Prediction at Scale

    Jun 18, 2024, 05:00 AM by User Not Found
    Bio-IT World | AlphaFold was revolutionary to protein scientists and their work, but as soon as the new capabilities became clear, scientific demand exploded. Regeneron engineers used the AlphaFold2 model to create a custom, cloud-based solution to allow analysis of thousands of protein binding partners in parallel.
    Full story
  • ProPharma Honored with 2024 CRO Leadership Award

    Jun 14, 2024, 07:16 AM by
    ProPharma, the world’s largest research consulting organization (RCO), a leading global provider of regulatory, clinical, and compliance services for the life sciences industry is pleased to announce it received a 2024 CRO Leadership Award.
    Full story
  • Huateng Pharma to Exhibit at CPHI China 2024

    Jun 14, 2024, 07:16 AM by
    Full story
  • MIB Agents’ Community of Families Has Awarded Over $1.9M in Grants to Research Pediatric Bone Cancer

    Jun 13, 2024, 08:54 AM by
    Full story
  • Uppsala University Hospital chooses AI-based Qlucore Insights to develop precision diagnostics

    Jun 13, 2024, 08:54 AM by
    Please see latest news from Qlucore who has signed an agreement with Uppsala University Hospital. The Hospital will use the Qlucore Insights software to improve the analysis of acute lymphoblastic leukemia (ALL) in children. Please get in touch if you require further information.
    Full story
  • Onyx Scientific Aims for European Growth with New BD Hire

    Jun 13, 2024, 08:54 AM by
    Small molecule specialists Onyx Scientific has made a significant new addition to its commercial team with the appointment of Courtnie Thomas Wilks as Business Development Manager for the UK and Europe.
    Full story
  • New Research Illustrates How to Drive Earlier Diagnosis and Treatment of Kidney Disease

    Jun 13, 2024, 08:54 AM by
    A new survey by Phreesia, in partnership with the National Kidney Foundation, finds that discussions between patients and providers, and patient activation, are key to helping high-risk patients take preventive actions to manage their kidney health.
    Full story
  • Mage Biologics announces first subject dosed in a Phase 1 trial with MB-001, an orally administered antibody for Inflammatory Bowel Disease

    Jun 13, 2024, 08:54 AM by
    Mage Biologics (“Mage”) announces it has dosed the first study participant in a first-in-human study of MB-001, a best-in-class orally administered antibody designed for the treatment of inflammatory bowel disease (IBD).
    Full story
  • «
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27 (current)
  • 28
  • 29
  • 30
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy